Codex @codex  0

A deoxynucleoside triphosphate analogue with $3^{\prime }$-H in place of $3^{\prime }$-OH, used in Sanger sequencing.

DNA sequencing determines the order of nucleotide bases in DNA. Sequence data can test molecular rearrangements, as in the functional plastid-to-nucleus gene transfer experiment, or support phylogenetics after a suitable sequence alignment.

An ordered nucleotide sequence answers a different question from fragment size. The eight-nucleotide strands ACGTTAGC and AACCGGTT have equal lengths and identical counts of adenine, cytosine, guanine and thymine, yet different orders. A length-compatible gel band therefore cannot identify either strand by itself. Sanger sequencing makes length informative by deliberately coupling each stopping position to the identity of its last added nucleotide.

That coupling is the beautiful experimental idea: convert an invisible order into a collection of ordered endpoints. Sanger ladder reading recovers the newly synthesized strand; base pairing and the reverse complement then connect that readout to the original template. The distinction also matters when checking a mutation: a reliable local nucleotide sequence supports a particular molecular change, while its effect on a phenotype requires additional evidence.

Frederick Sanger coauthored DNA sequencing by chain termination. Incorporation of a chain-terminating nucleotide creates fragments whose lengths report the positions of a particular base.

Resolving fragments by length converts a biochemical copying reaction into sequence information. The key chemical distinction is that a terminating nucleotide lacks the group required for continued chain extension.^[ref]

A biochemist known for protein and DNA sequencing, including Sanger sequencing.

Nobel Prize record: www.nobelprize.org/nomination/archive/show_people.php?id=8092

Maxam-Gilbert sequencing determines a DNA nucleotide sequence by base-selective chemical cleavage of end-labelled molecules, followed by polyacrylamide gel electrophoresis and autoradiography. Allan M. Maxam and Walter Gilbert's 1977 paper uses fragment lengths to locate attacked bases along the labelled strand. Sanger sequencing instead creates endpoints during DNA synthesis; the chemical method starts with the strand whose sequence is wanted.^[ref]

The label is crucial: each visible fragment shares one identifiable end, making its length a positional ruler. The paper allows either a 5′ or a 3′ terminal label and demonstrates separately resolved, 5′-labelled strands. Chemical modification must be partial, so that many molecules retain different cleavage positions. Destroying every susceptible site on every molecule would erase much of the distant sequence from the labelled fragments.^[ref]

The original four displays preferentially reveal guanine, preferentially reveal adenine, reveal cytosine and thymine together, and reveal cytosine alone. The purine displays use unequal reactivity rather than four perfectly exclusive reactions. Comparing parallel lanes supplies redundant information: a signal in the cytosine/thymine display but not the cytosine display identifies thymine. A sequence of four interior cleavage positions assigned A, C, T and G in order of increasing distance from a 5′ label identifies $5^{\prime }\text{-ACTG-}{3}^{\prime }$ at those positions. The nucleotide sequence of the opposite strand requires the reverse complement and its orientation.

A subtle experimental point prevents an off-by-one interpretation: the observed fragment ends immediately before the base destroyed by the chemical attack. The base assigned to a band is the attacked base, not an intact last base carried by that fragment. The 1977 example used a 64-base-pair lac operon fragment and denaturing gels; the authors read 62 bases of each strand and cross-checked the complementary sequences.^[ref]

An original Poisson distribution model illustrates why partial cleavage matters. If the number of attacks on a molecule has mean $\lambda$, thenAt $\lambda =0.1$, about $90.48\%$ are unhit, $9.05\%$ singly hit and $0.47\%$ multiply hit. At $\lambda =1$, the multiply-hit fraction rises to $26.42\%$. This independent-site model is an illustration, not a fitted description of the paper's sequence-dependent reaction rates. Gel resolution, incomplete specificity and multiple hits can all limit the recovered sequencing read.

The repetitive tract can cause DNA polymerase slippage during PCR amplification or the sequencing extension itself, generating stutter products. A heterozygous length variant creates overlapping Sanger sequencing traces downstream of the indel because the two templates lose register; this does not by itself indicate random sequencing failure. Tumor heterogeneity or contamination by normal tissue can add further mixed templates. Avoid creating or obscuring the mutation during amplification and avoid interpreting a mixed trace as one clean allele. Use a suitable high-fidelity DNA polymerase, independent amplifications and bidirectional reads, and resolve individual alleles by molecular cloning or an appropriate single-molecule/amplicon sequencing method if necessary. Check for non-specific products and allelic dropout caused by variation in a primer-binding site.

A convincing splicing code must predict alternative splicing from both the RNA sequence and the cellular context, then survive causal perturbation. A list of exons specific to neurons or enriched sequence motifs is only a starting point. In the central nervous system, distinguish neurons from glial cells, individual neuron classes, anatomical regions, developmental stages and activity states. Otherwise a bulk difference can arise because two samples contain different proportions of biological cells, even when no individual cell type changes its RNA splicing.

Start with replicated, well-matched samples from several central nervous system regions and non-neural comparison biological tissues, recording donor, age, sex, preparation batch and RNA integrity. Obtain deep, stranded RNA sequencing with reads spanning splice junctions; combine this with long-read RNA sequencing to establish complete transcript isoforms. Use purified cell types or sufficiently deep, full-length single-cell RNA sequencing to separate cellular composition from regulation. Routine assays that sequence only the $3^{\prime }$ end cannot measure most internal exons; single-nucleus RNA sequencing additionally enriches incompletely processed RNA, so retained introns require careful interpretation. A matched bulk or purified-cell dataset supplies coverage that sparse individual-cell observations lack.

Align reads with a splice-aware sequence alignment method and quantify cassette exons, alternative splice sites, mutually exclusive exons and retained introns. Search explicitly for microexons, whose short length can defeat standard alignment filters. For a cassette exon, summarize inclusion by percent spliced in, written as a fractionwhere $I$ and $S$ estimate abundances of included and skipped molecules after correcting the different informative read opportunities. Adding the two inclusion-junction counts and comparing their sum directly with a single skipping-junction count would bias this estimate. Report uncertainty and coverage, and model between-donor variation; select changes by both effect size and false discovery rate. Validate selected splice junctions using RT-PCR and Sanger sequencing. Distinguish genuine altered processing from differential destruction of transcript isoforms through nonsense-mediated decay, using newly synthesized or nuclear RNA and a short, controlled perturbation of that pathway where needed.

Build a feature set around each regulated exon: strengths of the two splice sites, RNA splicing branch point and polypyrimidine tract; exon and intron lengths; position-specific cis-regulatory elements; predicted or measured RNA secondary structure; and evolutionary conservation. Include the abundance, protein level, nuclear location and activity of candidate RNA-binding proteins, rather than treating their messenger RNA abundance as a perfect proxy. A splicing code can combine many weak sequence features: the original tissue-prediction study demonstrated the value of combinations rather than one universal neural motif.^[ref]

Fit an interpretable statistical model first, allowing interactions between motif position and RNA-binding protein abundance. Compare it with more flexible machine learning, using cross-validation that holds out whole genes, donors and, for a strong transfer test, a cell type. Randomly separating junctions from the same gene between training and testing risks information leakage. Compare against sequence-only, context-only and expression-matched baseline predictors. Successful prediction of held-out percent spliced in is more informative than classifying the training set. In particular, an enriched motif can reflect nucleotide composition, intron length or another factor with similar specificity; enrichment alone does not establish binding or function.

Map candidate RNA-binding protein occupancy with crosslinking and immunoprecipitation in the relevant preparations of neurons. Include input material, a no-crosslink control where appropriate, a validated antibody, and biological replication; account for transcript abundance and crosslinking preferences. Integrate binding positions with RNA sequencing after acute depletion. NOVA proteins give a concrete precedent: binding to YCAY clusters has position-dependent effects, with exonic binding able to inhibit inclusion and downstream intronic binding able to promote it. Here Y denotes a pyrimidine nucleobase. Thus the same motif can support opposite predictions at different positions.^[ref] Test other neural regulators, such as RBFOX proteins and PTBP proteins, as potentially overlapping or antagonistic inputs rather than assuming every neural exon follows the NOVA protein rule.

Finally, make the predictions experimentally vulnerable. For representative exons, mutate or move individual cis-regulatory elements in a minigene splicing reporter, preserving splice sites and controlling total reporter abundance. Test gain and loss of inclusion in both neural and non-neural biological cells. Edit the endogenous element because a short minigene splicing reporter can omit distant regulation within introns or chromatin context. Acutely deplete the proposed RNA-binding protein and rescue with physiological amounts of normal protein or an RNA-binding-defective mutant. Combined depletion tests redundancy; motif mutation plus factor depletion tests whether both act through the same element. A particularly strong result is the predicted reversal after moving a binding site from a repressive to an activating position. Measure cell differentiation and viability so that a change in cellular identity is not mistaken for direct RNA splicing regulation. The resulting code is a tested, context-dependent set of regulatory rules, with an explicit domain of validity.

Consider an original teaching template whose next eight positions, encountered after the sequencing primer, areThe sequencing primer binds an upstream region omitted from this display; the template also continues beyond the eight positions shown. DNA polymerase encounters the displayed template from left to right. Applying base pairing at each successive position gives the extensionThese eight letters are added material, not the entire primer-containing DNA molecule.

Here is the full endpoint accounting. A terminal letter denotes an incorporated terminating nucleotide; all preceding letters of that extension were supplied by ordinary deoxynucleoside triphosphates.

The shortest fragments migrate farthest, placing position 1 at the bottom. Reading upward, the lane labels spell A, C, G, T, T, A, G, C: the new strand in its $5^{\prime }$-to-$3^{\prime }$ direction. The adjacent T bands at positions 4 and 5 encode two separate additions. A single unresolved T patch would leave that count uncertain. In the A lane, the position-6 fragment passed position 1 using ordinary dATP and stopped at position 6 using ddATP; it does not skip the intervening nucleotides.

The common sequencing primer is an offset. For primer length $p$, endpoint $n$ has length $p+n$ nucleotides. With an illustrative $p=20$, the drawn fragments would contain 21 through 28 nucleotides, and adjacent endpoints still differ by one. Subtracting the common $p$ preserves their order because $(p+n+1)-(p+n)=1$. This supplies a short justification for Sanger ladder reading: nested fragments share a start, length orders their endpoints, and lane membership supplies each endpoint's letter. A missing early band cannot be relabeled position 1 without independent evidence about the starting point.

To report the original template region, first complement the readout in aligned orientation:If the requested answer is that template written $5^{\prime }$ to $3^{\prime }$, reverse the aligned template to obtain $5^{\prime }\text{-}\mathrm{GCTAACGT}\text{-}{3}^{\prime }$, the reverse complement of the readout. Reversing the readout alone would give CGATTGCA and would be wrong. Complementing without reversing gives the correct template letters in its displayed $3^{\prime }$-to-$5^{\prime }$ direction, but not in the usual reporting convention. Specify the strand and its direction before transforming the answer.

Sanger sequencing determines a DNA nucleotide sequence by extending a common sequencing primer and occasionally incorporating a dideoxynucleoside triphosphate. A normal deoxynucleoside triphosphate already has hydrogen in place of a $2^{\prime }$ hydroxy group; it retains the $3^{\prime }$ hydroxy group. A dideoxynucleoside triphosphate lacks that $3^{\prime }$ hydroxy group too. It can join the growing strand because the preceding nucleotide supplies the reacting $3^{\prime }$ hydroxy group. Once incorporated, its own $3^{\prime }$ end cannot form the next phosphodiester bond. Thus the blocked step is the next addition, not attachment of the terminator itself.^[ref]

In the historical four-reaction format, each tube receives copies of the same template, the same sequencing primer, a DNA polymerase and all four ordinary deoxynucleoside triphosphates. The tubes differ in their terminating substrate: ddATP, ddCTP, ddGTP or ddTTP. In the A reaction, ordinary dATP can allow copying to continue past one A position, whereas incorporation of ddATP stops another copy there. Competition produces a family of endpoints, rather than every strand stopping at the first A. Adjusting substrate proportions makes later endpoints detectable. A lane identifies the terminating nucleobase in the new strand, not the complementary template letter.^[ref]

The readout requires gel electrophoresis capable of separating single-stranded DNA fragments differing by one nucleotide. Historical denaturing polyacrylamide gel electrophoresis suppressed strand folding and resolved these adjacent lengths; radioactive labels were detected by autoradiography. An ordinary agarose gel electrophoresis comparison with a 100-base pair DNA ladder does not supply that resolution. Four separate reaction lanes carry the identities in this format.^[ref]